Inhibition of EGFR expression with chitosan/alginate nanoparticles encapsulating antisense oligonucleotides in T47D cell line using RT-PCR and immunocytochemistry

Carbohydrate Polymers

Volumn 80, Issue 4, 2010, Pages 1042-1047

  Gazori, Taraneh ^a   Haririan, Ismaeil ^a,b   Fouladdel, Shamileh ^a   Namazi, Alireza ^a   Nomani, Alireza ^a,c   Azizi, Ebrahim ^a,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antisense; Chitosan alginate nanoparticles; Cytotoxicity; EGFR; Immunocytochemistry; RT PCR

Indexed keywords

ANTISENSE; ANTISENSE OLIGONUCLEOTIDES; BREAST CANCER CELLS; CANCER CELLS; CELL LINES; CHITOSAN/ALGINATE NANOPARTICLES; EPIDERMAL GROWTH FACTOR RECEPTORS; IMMUNOCYTOCHEMISTRY; LOADING EFFICIENCY; TOXIC PROPERTIES;

CELL CULTURE; CELLS; CHLORINE COMPOUNDS; OLIGONUCLEOTIDES;

NANOPARTICLES;

EID: 77950368148     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2010.01.022     Document Type: Article

References (18)

1. Akhtar S., and Juliano R.L. Cellular uptake and intracellular fate of antisense oligonucleotides. Trends in Cell Biology 2 (1992) 139-144
2. Bazargan L., Fouladdel Sh., Shafiee A., Amini M., Ghaffari S.M., and Azizi E. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro. Cell Biology and Toxicology 24 (2008) 165-174
3. Borges O., Cordeiro-da-Silva A., Romeijn S.G., Amidi M., Sousa A., Borchard G., et al. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. Journal of Controlled Release 114 (2006) 348-358
4. Ciofani G., Raffa V., Menciassi A., and Dario P. Alginate and chitosan particles as drug delivery system for cell therapy. Biomedical Microdevices 10 (2008) 131-140
5. Davda J., and Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. International Journal of Pharmaceutics 233 (2002) 51-59
6. Douglas K.L., Piccirillo C.A., and Tabrizian M. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles. Journal of Controlled Release 115 (2006) 354-361
7. Fattal E., and Bochot A. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. International Journal of Pharmaceutical Sciences 364 (2008) 237-248
8. Gazori T., Khoshayand M.R., Azizi E., Yazdizade P., Nomani A., and Haririan I. Evaluation of alginate/chitosan nanoparticles as antisense delivery vector: Formulation, optimization and invitro characterization. Carbohydrate Polymers 7 33 (2009) 599-606
9. Hussain M., Shchepinov M.S., Muhammad Sohail M., Ibrahim F., Benter I.F., Hollins A.J., et al. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. Journal of Controlled Release 99 (2004) 139-155
10. Ishii T., Okahata Y., and Toshinori Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochimica et Biophysica Acta 1514 (2001) 51-64
11. Kaabinejadian S., Fouladdel Sh., Ramezani M., and Azizi E. P53 expression in MCF7, T47D and MDA-MB468 breast cancer cell lines treated with Adriamycin using RT-PCR and immunocytochemistry. Journal of Biological Sciences 8 2 (2008) 380-385
12. Kim E.S., Khuri F.R., and Herbst R.S. Epidermal growth factor receptor biology. Current Opinion in Oncology 13 (2001) 506-513
13. Kim S.T., and Kim C.K. Water-soluble chitosan-based antisense oligodeoxynucleotide of interleukin-5 for treatment of allergic rhinitis. Biomaterials 28 (2007) 3360-3368
14. Mansouri P., Lavigne P., Corsi K., Benderdour M., Beaumont E., and Fernandes J.C. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: Strategies to improve transfection efficiency. European Journal of Pharmaceutics and Biopharmaceutics 57 (2004) 1-8
15. Merdan T., Kopecek J., and Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Advanced Drug Delivery Reviews 54 (2002) 715-758
16. Nafee N., Taetz S., Schneider M., Schaefer U.F., and Lehr C.M. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: Effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine: Nanotechnology, Biology, and Medicine 3 (2007) 173-183
17. Taetz S., Nafee N., Beisner J., Piotrowska K., Baldes C., Mürdter T.E., et al. The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 20-O-methyl-RNA directed against telomerase in lung cancer cells. European Journal of Pharmaceutics and Biopharmaceutics 72 (2009) 358-369
18. Valdehita A., Bajo A.M., Schally A.V., Varga J.L., Carmena M.J., and Prieto J.C. Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells. Molecular and Cellular Endocrinology 302 (2009) 41-48